Iron and CF-related anemia: Expanding clinical and biochemical relationships

Introduction This cross‐sectional study was conducted to assess the relationship between iron levels in the plasma and sputum of cystic fibrosis (CF) patients. Methods Demographic, clinical, and iron‐related laboratory data were prospectively obtained from 25 patients with stable clinical features a...

Full description

Saved in:
Bibliographic Details
Published inPediatric pulmonology Vol. 46; no. 2; pp. 160 - 165
Main Authors Gifford, A.H., Miller, S.D., Jackson, B.P., Hampton, T.H., O'Toole, G.A., Stanton, B.A., Parker, H.W.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.02.2011
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction This cross‐sectional study was conducted to assess the relationship between iron levels in the plasma and sputum of cystic fibrosis (CF) patients. Methods Demographic, clinical, and iron‐related laboratory data were prospectively obtained from 25 patients with stable clinical features and 14 patients with worsened clinical features since their most recent evaluations. Results Compared to patients with stable clinical features, those who experienced clinical deterioration demonstrated significantly worse lung function and were more frequently malnourished and diabetic. Members of the latter group were also significantly more hypoferremic and had higher sputum iron content than patients with stable clinical features. No significant correlation was found between plasma and sputum iron levels when the groups were analyzed together and separately. Conclusions Sputum iron content does not correlate with iron‐related hematologic tests. Hypoferremia is common in CF and correlates with poor lung function and overall health. Pediatr. Pulmonol. 2011; 46:160–165. © 2011 Wiley‐Liss, Inc.
Bibliography:istex:69B99679E4F5BF790C07D380EF78CEC2F0A5F708
Data from this study were presented in abstract form at the 2009 North American Cystic Fibrosis Conference in Minneapolis, Minnesota, USA, October 15-17, 2009.
National Institutes of Health - No. R01-HL074175-04-06; No. P20 RR-018787
ark:/67375/WNG-7TCNQQVQ-J
ArticleID:PPUL21335
Data from this study were presented in abstract form at the 2009 North American Cystic Fibrosis Conference in Minneapolis, Minnesota, USA, October 15–17, 2009.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:8755-6863
1099-0496
DOI:10.1002/ppul.21335